Cargando…

Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome

To examine serum interleukin 18 (IL-18), fetuin-A, soluble intercellular adhesion molecule-1 (sICAM-1), and endothelin-1 (ET-1) levels in ankylosing spondylitis (AS), psoriatic arthritis (PsA), and Synovitis Acne Pustulosis Hyperostosis Osteitis syndrome (SAPHO). We studied 81 AS, 76 PsA, and 34 SAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Przepiera-Będzak, Hanna, Fischer, Katarzyna, Brzosko, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000653/ https://www.ncbi.nlm.nih.gov/pubmed/27527149 http://dx.doi.org/10.3390/ijms17081255

Ejemplares similares

Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2015)

Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2018)

SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2020)

Sacroiliitis and Spondylitis with Sternoclavicular Hyperostosis: SAPHO or an Ankylosing Spondylitis Variant?
por: Shen, Kai, et al.
Publicado: (2016)

Increased Serum Interleukin 10 Levels Are Associated with Increased Disease Activity and Increased Risk of Anti-SS-A/Ro Antibody Positivity in Patients with Systemic Lupus Erythematosus
por: Winikajtis-Burzyńska, Agnieszka, et al.
Publicado: (2023)

Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
por: Fischer, Katarzyna, et al.
Publicado: (2017)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Extra-Articular Symptoms in Constellation with Selected Serum Cytokines and Disease Activity in Spondyloarthritis
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2016)

Axial spondyloarthritis and inflammatory bowel disease: association between disease activity and endothelial dysfunction markers
por: Przepiera-Będzak, Hanna, et al.
Publicado: (2021)

SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report
por: Yuan, Fangfang, et al.
Publicado: (2022)

Successful Treatment of SAPHO Syndrome Complicated with Ankylosing Spondylitis by Secukinumab: A Case Report
por: Tu, Wei, et al.
Publicado: (2023)

Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
por: Tuylu, Tugba, et al.
Publicado: (2014)

Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus
por: Fischer, Katarzyna, et al.
Publicado: (2022)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
por: Girbash, Ehab F., et al.
Publicado: (2023)

Detection of soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 in the effusion of otitis media with effusion
por: Ganbo, T., et al.
Publicado: (1995)

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma
por: Boyano, M D, et al.
Publicado: (2000)

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

Crevicular fluid levels of interleukin-8, interleukin-17 and soluble intercellular adhesion molecule-1 after regenerative periodontal therapy
por: Erdemir, Ebru Olgun, et al.
Publicado: (2015)

Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021)

Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy
por: Kim, Hyoun-Ah, et al.
Publicado: (2022)

Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis
por: Nielsen, Christel, et al.
Publicado: (2017)

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
por: Elewski, Boni E., et al.
Publicado: (2021)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA
por: Ogdie, Alexis, et al.
Publicado: (2021)

Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis
por: Bonek, Krzysztof, et al.
Publicado: (2022)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

MICA*019 Allele and Soluble MICA as Biomarkers for Ankylosing Spondylitis in Taiwanese
por: Wang, Chin-Man, et al.
Publicado: (2021)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2014)

Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
por: Aboud, Fatma Mohammed, et al.
Publicado: (2023)

Elevated levels of soluble intercellular adhesion molecule -1 in systemic lupus erythematosus
por: Kljukvina, N, et al.
Publicado: (2001)

Soluble intercellular adhesion molecule-1 is a prognostic marker in colorectal carcinoma
por: Schellerer, Vera S., et al.
Publicado: (2018)

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity
por: Chen, Bingni, et al.
Publicado: (2015)

Coexistence of Ankylosing Spondylitis and Neurofibromatosis Type 1
por: Gundogdu, Baris, et al.
Publicado: (2016)

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
por: Michelena, Xabier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6v1g5m9fe1e0bhb3h36ljd4g3